You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

131 Results
Guidelines and Advice
Status: In-Review
ID: 7-14
Version: 3
Dec 2018
Guidelines and Advice
Status: Current
ID: N/A
Version: Final
May 2018
Cancer facts
Jun 2019
Regimen
Cancer Type:
Hematologic, 
Rare Diseases, 
Sarcoma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
ODB - General Benefit
    prednisone
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
prednisone,
DOXOrubicin,
vinCRIStine,
cyclophosphamide
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jun 2019
Guidelines and Advice
Status: In-Review
ID: ES 15-16
Oct 2018
Statistical Reports
Apr 2018
Statistical Reports
Apr 2018
Guidelines and Advice
Status: In-Review
ID: GL-END 3-21
Jan 2018
Guidelines and Advice
Status: Archived
ID: 15-11
Version: 3
Jan 2018
Statistical Reports
Jan 2018
Statistical Reports
Jan 2018

Pages